When a company built on the promise of reliable access to orbit finds itself unable to fly, the market tends to price in fear before it prices in recovery. Rocket Lab, grounded by operational constraints that have weighed on its stock, now finds itself the subject of a contrarian wager from a Wall Street analyst who sees the current anxiety as an overreaction — and the company's underlying mission as intact. It is an old story in the long arc of aerospace: the question is never only whether a vehicle can be fixed, but whether the belief in it can be restored.